{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:55:01Z","timestamp":1788346501896,"version":"build-2803163510"},"reference-count":58,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,11,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Alloantibodies developing after exposure to red blood cell (RBC) alloantigens can complicate pregnancy and transfusion therapy. The only method currently available to actively inhibit RBC alloantibody formation is administration of antigen-specific antibodies, a phenomenon termed antibody-mediated immune suppression (AMIS). A well-known example of AMIS is RhD immune globulin prophylaxis to prevent anti-D formation in RhD\u2212 individuals. However, whether AMIS is specific or impacts alloimmunization to other antigens on the same RBC remains unclear. To evaluate the specificity of AMIS, we passively immunized antigen-negative recipients with anti-KEL or anti-hen egg lysozyme (HEL) antibodies, followed by transfusion of murine RBC expressing both the HEL-ovalbumin-Duffy (HOD) and human KEL antigens (HOD \u00d7 KEL RBC). Significant immunoglobulin G deposition on transfused HOD \u00d7 KEL RBC occurred in all passively immunized recipients. Complement deposition and antigen modulation of the KEL antigen occurred on transfused RBC only in anti-KEL\u2013treated recipients, whereas HEL antigen levels decreased only in the presence of anti-HEL antibodies. Western blot analysis confirmed the specificity of antigen loss, which was not attributable to RBC endocytosis and appears distinct for the 2 antigens. Specifically, removal of KEL was attenuated by clodronate treatment, whereas loss of HEL was unaffected by clodronate in vivo but sensitive to protease treatment in vitro. Antigen-specific modulation correlated with antigen-specific AMIS, with anti-KEL treated recipients forming antibodies to the HOD antigen and anti-HEL\u2013treated recipients developing antibodies to the KEL antigen. Together, these results demonstrate that passively administered antibodies can selectively inhibit the immune response to a specific antigen.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018018408","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T12:53:37Z","timestamp":1541768017000},"page":"2986-3000","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":47,"title":["Antibody-mediated immune suppression by antigen modulation is antigen-specific"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-2674","authenticated-orcid":false,"given":"Cheryl L.","family":"Maier","sequence":"first","affiliation":[{"name":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Mener","sequence":"additional","affiliation":[{"name":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema R.","family":"Patel","sequence":"additional","affiliation":[{"name":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Jajosky","sequence":"additional","affiliation":[{"name":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley L.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M.","family":"Arthur","sequence":"additional","affiliation":[{"name":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne E.","family":"Hendrickson","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[{"name":"Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,11,9]]},"reference":[{"issue":"2","key":"2020021108400589300_B1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/vox.12265","article-title":"Haemolytic disease of the fetus and newborn","volume":"109","author":"de Haas","year":"2015","journal-title":"Vox Sang"},{"issue":"6","key":"2020021108400589300_B2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/MOH.0000000000000277","article-title":"Red blood cell alloimmunization: new findings at the bench and new recommendations for the bedside","volume":"23","author":"Hendrickson","year":"2016","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"2020021108400589300_B3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0022172400014376","article-title":"An experimental study of haemolytic disease of the newborn due to isoimmunization of pregnancy","volume":"47","author":"Heard","year":"1949","journal-title":"J Hyg (Lond)"},{"issue":"3","key":"2020021108400589300_B4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tmrv.2014.04.008","article-title":"Red blood cell alloimmunization mitigation strategies","volume":"28","author":"Hendrickson","year":"2014","journal-title":"Transfus Med Rev"},{"issue":"10","key":"2020021108400589300_B5","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","article-title":"Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease","volume":"103","author":"Chonat","year":"2018","journal-title":"Haematologica"},{"issue":"9","key":"2020021108400589300_B6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1537-2995.2001.41091086.x","article-title":"Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial","volume":"41","author":"Vichinsky","year":"2001","journal-title":"Transfusion"},{"issue":"8","key":"2020021108400589300_B7","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.03045.x","article-title":"Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME)","volume":"51","author":"Lasalle-Williams","year":"2011","journal-title":"Transfusion"},{"key":"2020021108400589300_B8"},{"issue":"3712","key":"2020021108400589300_B9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1126\/science.151.3712.828","article-title":"Rh factor: prevention of isoimmunization and clinical trial on mothers","volume":"151","author":"Freda","year":"1966","journal-title":"Science"},{"issue":"3","key":"2020021108400589300_B10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1537-2995.1968.tb04895.x","article-title":"Results of clinical trials of RhoGAM in women","volume":"8","author":"Pollack","year":"1968","journal-title":"Transfusion"},{"issue":"5238","key":"2020021108400589300_B11","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/bmj.1.5238.1486","article-title":"Experimental studies on the prevention of Rh haemolytic disease","volume":"1","author":"Finn","year":"1961","journal-title":"BMJ"},{"issue":"5336","key":"2020021108400589300_B12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/bmj.1.5336.979","article-title":"Further experimental studies on the prevention of Rh haemolytic disease","volume":"1","author":"Clarke","year":"1963","journal-title":"BMJ"},{"issue":"5481","key":"2020021108400589300_B13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bmj.1.5481.213","article-title":"Dose of anti-D gamma-globulin in prevention of Rh-haemolytic disease of the newborn","volume":"1","author":"Clarke","year":"1966","journal-title":"BMJ"},{"issue":"4","key":"2020021108400589300_B14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.4049\/jimmunol.1700874","article-title":"Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms","volume":"200","author":"Cruz-Leal","year":"2018","journal-title":"J Immunol"},{"issue":"26","key":"2020021108400589300_B15","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1182\/blood-2016-06-724732","article-title":"Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice","volume":"128","author":"Liu","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2020021108400589300_B16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1471-4906(00)01801-9","article-title":"Mechanism of anti-D-mediated immune suppression--a paradox awaiting resolution?","volume":"22","author":"Kumpel","year":"2001","journal-title":"Trends Immunol"},{"issue":"2009","key":"2020021108400589300_B17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/asheducation-2009.1.185","article-title":"Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn","author":"Brinc","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"2020021108400589300_B18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MOH.0b013e32833199ed","article-title":"Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn: what can we learn from rodent models?","volume":"16","author":"Brinc","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"2020021108400589300_B19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fimmu.2017.00238","article-title":"Epitope-specific suppression of IgG responses by passively administered specific IgG: evidence of epitope masking","volume":"8","author":"Bergstr\u00f6m","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"2020021108400589300_B20","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.1302287","article-title":"Antibody-mediated immune suppression of erythrocyte alloimmunization can occur independently from red cell clearance or epitope masking in a murine model","volume":"193","author":"Yu","year":"2014","journal-title":"J Immunol"},{"issue":"3","key":"2020021108400589300_B21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1537-2995.1968.tb04891.x","article-title":"Antibody-mediated immune suppression to the Rh factor: animal models suggesting mechanism of action","volume":"8","author":"Pollack","year":"1968","journal-title":"Transfusion"},{"issue":"2","key":"2020021108400589300_B22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2141.2007.06764.x","article-title":"IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?","volume":"139","author":"Brinc","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"2020021108400589300_B23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood.V86.5.1701.bloodjournal8651701","article-title":"Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers","volume":"86","author":"Kumpel","year":"1995","journal-title":"Blood"},{"issue":"10","key":"2020021108400589300_B24","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.4049\/jimmunol.1300885","article-title":"Antigen modulation confers protection to red blood cells from antibody through Fc\u03b3 receptor ligation","volume":"191","author":"Stowell","year":"2013","journal-title":"J Immunol"},{"issue":"10","key":"2020021108400589300_B25","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.3324\/haematol.2015.128603","article-title":"Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model","volume":"100","author":"Stowell","year":"2015","journal-title":"Haematologica"},{"issue":"5962","key":"2020021108400589300_B26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/bmj.2.5962.57","article-title":"Mechanism of Rh prophylaxis: an experimental study on specificity of immunosuppression","volume":"2","author":"Woodrow","year":"1975","journal-title":"BMJ"},{"issue":"3","key":"2020021108400589300_B27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0887-7963(88)70039-5","article-title":"The prevention of Rh immunization","volume":"2","author":"Bowman","year":"1988","journal-title":"Transfus Med Rev"},{"issue":"2 Pt 2","key":"2020021108400589300_B28","first-page":"418","article-title":"The protective action of ABO incompatibility on Rh isoimmunization and Rh hemolytic disease-theoretical and clinical implications","volume":"11","author":"Levine","year":"1959","journal-title":"Am J Hum Genet"},{"issue":"9","key":"2020021108400589300_B29","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/trf.12049","article-title":"Does Rh immune globulin suppress HLA sensitization in pregnancy?","volume":"53","author":"Kaufman","year":"2013","journal-title":"Transfusion"},{"issue":"4","key":"2020021108400589300_B30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus Med Rev"},{"issue":"1","key":"2020021108400589300_B31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-2115(00)00428-0","article-title":"Non-anti-D antibodies in red-cell alloimmunization","volume":"92","author":"Moise","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"2020021108400589300_B32","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1182\/blood-2013-03-488874","article-title":"Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus\/newborn in a murine model","volume":"122","author":"Stowell","year":"2013","journal-title":"Blood"},{"issue":"11","key":"2020021108400589300_B33","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood-2009-04-214387","article-title":"Minor histocompatibility antigens on transfused leukoreduced units of red blood cells induce bone marrow transplant rejection in a mouse model","volume":"114","author":"Desmarets","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2020021108400589300_B34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1182\/blood-2016-01-692178","article-title":"Antibody-mediated immune suppression is improved when blends of anti-RBC monoclonal antibodies are used in mice","volume":"128","author":"Bernardo","year":"2016","journal-title":"Blood"},{"issue":"12","key":"2020021108400589300_B35","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/j.1537-2995.2012.03647.x","article-title":"Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fc\u03b3 receptors in a murine model","volume":"52","author":"Liepkalns","year":"2012","journal-title":"Transfusion"},{"issue":"3","key":"2020021108400589300_B36","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.bjc.6603240","article-title":"Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach","volume":"95","author":"Zeisberger","year":"2006","journal-title":"Br J Cancer"},{"issue":"7","key":"2020021108400589300_B37","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.4049\/jimmunol.1601736","article-title":"Antigen density dictates immune responsiveness following red blood cell transfusion","volume":"198","author":"Arthur","year":"2017","journal-title":"J Immunol"},{"issue":"3","key":"2020021108400589300_B38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2005-03-1040","article-title":"Nonhemolytic antibody-induced loss of erythrocyte surface antigen","volume":"106","author":"Zimring","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2020021108400589300_B39","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1182\/blood-2007-04-083097","article-title":"Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes","volume":"110","author":"Zimring","year":"2007","journal-title":"Blood"},{"issue":"10","key":"2020021108400589300_B40","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2013-06-508952","article-title":"A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation","volume":"122","author":"Girard-Pierce","year":"2013","journal-title":"Blood"},{"issue":"14","key":"2020021108400589300_B41","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2015-10-673426","article-title":"CD8+ T cells mediate antibody-independent platelet clearance in mice","volume":"127","author":"Arthur","year":"2016","journal-title":"Blood"},{"issue":"22","key":"2020021108400589300_B42","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood-2016-11-749432","article-title":"Daratumumab (anti-CD38) induces loss of CD38 on red blood cells","volume":"129","author":"Sullivan","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2020021108400589300_B43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1182\/bloodadvances.2017010124","article-title":"Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice","volume":"2","author":"Patel","year":"2018","journal-title":"Blood Adv"},{"key":"2020021108400589300_B44","author":"Mener"},{"issue":"1","key":"2020021108400589300_B45","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.immunol.16.1.421","article-title":"Divergent roles for Fc receptors and complement in vivo","volume":"16","author":"Ravetch","year":"1998","journal-title":"Annu Rev Immunol"},{"issue":"14","key":"2020021108400589300_B46","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"2020021108400589300_B47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fcgamma receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"issue":"4","key":"2020021108400589300_B48","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.3390\/membranes7040056","article-title":"A comprehensive review of our current understanding of red blood cell (RBC) glycoproteins","volume":"7","author":"Aoki","year":"2017","journal-title":"Membranes (Basel)"},{"issue":"2","key":"2020021108400589300_B49","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/trf.14452","article-title":"Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion","volume":"58","author":"Sullivan","year":"2018","journal-title":"Transfusion"},{"issue":"14","key":"2020021108400589300_B50","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/bloodadvances.2017004671","article-title":"Human and murine splenic neutrophils are potent phagocytes of IgG-opsonized red blood cells","volume":"1","author":"Meinderts","year":"2017","journal-title":"Blood Adv"},{"issue":"14","key":"2020021108400589300_B51","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood-2017-08-743229","article-title":"Mechanisms of platelet clearance and translation to improve platelet storage","volume":"131","author":"Quach","year":"2018","journal-title":"Blood"},{"issue":"7","key":"2020021108400589300_B52","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2007-03-083105","article-title":"Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells","volume":"110","author":"Hendrickson","year":"2007","journal-title":"Blood"},{"issue":"3","key":"2020021108400589300_B53","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4049\/jimmunol.1700401","article-title":"Type I IFN is necessary and sufficient for inflammation-induced red blood cell alloimmunization in mice","volume":"199","author":"Gibb","year":"2017","journal-title":"J Immunol"},{"issue":"1","key":"2020021108400589300_B54","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/trf.12217","article-title":"Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies","volume":"54","author":"Stowell","year":"2014","journal-title":"Transfusion"},{"issue":"10","key":"2020021108400589300_B55","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJMc1205644","article-title":"IVIG--a hemolytic culprit","volume":"367","author":"Pintova","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2020021108400589300_B56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1537-2995.1987.27187121468.x","article-title":"Positive antiglobulin tests due to intravenous immunoglobulin in patients who received bone marrow transplant","volume":"27","author":"Robertson","year":"1987","journal-title":"Transfusion"},{"issue":"6","key":"2020021108400589300_B57","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/jdv.14671","article-title":"Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters","volume":"32","author":"Cicha","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2020021108400589300_B58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/tme.12083","article-title":"Intravenous immunoglobulin-induced haemolysis: a case report and review of the literature","volume":"24","author":"Desborough","year":"2014","journal-title":"Transfus Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/21\/2986\/1629901\/advances018408.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/21\/2986\/1629901\/advances018408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:16:12Z","timestamp":1581412572000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/21\/2986\/16218\/Antibodymediated-immune-suppression-by-antigen"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,9]]},"references-count":58,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2018,11,13]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018018408","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,9]]}}}